I

Inmagene Biopharmaceuticals

46 employees

Inmagene is a clinical-stage biotech company developing innovative and differentiated therapies for immunological and inflammatory diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Biotech
Autoimmune Diseases
Drug Development
Biopharma
Allergic Diseases
Pharmaceuticals

Date founded

2019

Funding rounds raised

Total raised

$100M

from 6 investors over 6 rounds

I

Inmagene Biopharmaceuticals raised $100M on June 1, 2021

Investors: 深圳前海勤智国际资本管理有限公司, 北京昆仑星河投资管理有限公司, VMS Group and TMT Investments PLC

I

Inmagene Biopharmaceuticals raised $21M on November 8, 2020

Investors: Kunlun Capital and 祥恩股权投资管理(上海)有限公司

FAQ